In this study, we found that IMD can alleviate DCM by up-regulating CPT-1β through activation of the PI3K/Akt signaling pathway, which is consistent with previous studies [59,66,75]. The gene discussed is CPT1B; the disease is familial dilated cardiomyopathy.